Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 25, 2022

BUY
$16.32 - $26.37 $1,632 - $2,637
100 New
100 $1,000
Q4 2021

Jan 18, 2022

SELL
$21.19 - $31.29 $2,119 - $3,129
-100 Closed
0 $0
Q3 2021

Oct 26, 2021

BUY
$27.36 - $35.98 $2,736 - $3,597
100 New
100 $3,000
Q4 2020

Jan 21, 2021

SELL
$31.56 - $42.16 $93,259 - $124,582
-2,955 Closed
0 $0
Q3 2020

Oct 27, 2020

BUY
$23.19 - $41.61 $68,526 - $122,957
2,955 New
2,955 $98,000

Others Institutions Holding ALBO

About ALBIREO PHARMA, INC.


  • Ticker ALBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,612,500
  • Description
  • Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...
More about ALBO
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.